Valeant Pharmaceuticals (VRX) Stock: Headed Up On Upgrade
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is having a strong start to the trading session this morning, and for good reason. The company was the center of an analyst upgrade, leading to excitement among investors and sending the stock on a run for the top. Today, we’ll talk about: The upgrade; what we’re seeing from … Read more